Non-communicable disease

What is sepsis? How to spot, manage and prevent it

Retrieved on: 
Sunday, April 23, 2023

Sepsis, a life threatening condition, happens when the body has an excessive immune response to an infection in the blood stream.

Key Points: 
  • Sepsis, a life threatening condition, happens when the body has an excessive immune response to an infection in the blood stream.
  • The Conversation Africa’s Ina Skosana spoke to pathologists from the National Institute of Communicable Diseases about the illness and its impact.

What causes sepsis?

    • There are common causes of sepsis.
    • Infections of the central nervous system (meningitis) as well as skin and soft tissue (surgical site, wounds or burns) are also common causes of sepsis.

Who is at risk of sepsis?

    • But babies up to one month old and people older than 65 years have a higher risk of developing the condition.
    • Prolonged hospital stays or admission to an intensive care unit (ICU) can also increase the risk of sepsis.

What are the symptoms of sepsis and septic shock?


    Symptoms of sepsis are not specific. These may include one or more of these:
    Septic shock is a progression of sepsis. It’s characterised by hypotension (low blood pressure), hypovolaemia (loss of bodily fluids such as water and blood) and organ dysfunction. Patients typically present with extreme confusion or loss of consciousness.

How is sepsis and septic shock diagnosed?

    • There are various tests available to diagnose sepsis and septic shock.
    • Sepsis and septic shock are clinical syndromes defined by a combination of signs, symptoms, laboratory and physiological abnormalities.
    • A variety of clinical variables and tools such as vital signs (heart rate, respiratory rate, temperature and blood pressure), laboratory blood tests (confirmation of infection) and clinical examinations have to be reviewed for sepsis screening.

How is sepsis managed?

    • Patients with sepsis need close monitoring and treatment in a hospital ICU.
    • Intravenous fluids should be started as soon as possible, preferably within the first three hours of sepsis being identified.

How is sepsis prevented?

    • In healthcare facilities prevention of the sepsis include practising appropriate infection prevention and control measures which can reduce infections by 50%.
    • Recognising sepsis early and introducing antibiotics treatment early can reduce the likelihood of sepsis progressing to mortality.
    • Anyone who has signs and symptoms of sepsis, even when the underlying infection is not apparent, should seek medical care immediately.

Active Pharmaceutical Ingredients (API) Global Market Research Report 2023: A $388+ Billion Market by 2029 - Increasing Scope of HPAPI and Advanced Next Generation Biologics Markets - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 4, 2023

The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029" report has been added to ResearchAndMarkets.com's offering.
  • Whereas, growing scope for HPAPI and next generation therapeutics such as cell therapy and gene therapy, increasing patent expiration and trend of outsourcing are providing immense opportunity to the API market.
  • The global API market is mainly segmented based on synthesis, business type, application, and geography.
  • Based on synthesis, the API global market is segmented into synthetic API, biotech API and HPAPI.

Malaysia Clinical Labs Market is Expected to Reach More Than USD ~3000 Mn by 2027F Owing to Growing Medical Infrastructure and Investment in Better Healthcare Services: Ken Research

Retrieved on: 
Tuesday, February 7, 2023

There are 3185 (87.8%) private independent labs and 441 (12.2%) government independent labs in Philippines.

Key Points: 
  • There are 3185 (87.8%) private independent labs and 441 (12.2%) government independent labs in Philippines.
  • This will further lead to increase in market share in the overall Indonesia clinical laboratory market.
  • The Clinical Laboratories Market in the Vietnam has seen emergence of more than 20-30 players over the past 5 years.
  • Other players include Pathlab, Thonburi Clinical Labs, Bangkok Medical Labs, Medical Line Lab, Innotech Laboratories and others.

Malaysia Clinical Labs Market is Expected to Reach More Than USD ~3000 Mn by 2027F Owing to Growing Medical Infrastructure and Investment in Better Healthcare Services: Ken Research

Retrieved on: 
Tuesday, February 7, 2023

There are 3185 (87.8%) private independent labs and 441 (12.2%) government independent labs in Philippines.

Key Points: 
  • There are 3185 (87.8%) private independent labs and 441 (12.2%) government independent labs in Philippines.
  • This will further lead to increase in market share in the overall Indonesia clinical laboratory market.
  • The Clinical Laboratories Market in the Vietnam has seen emergence of more than 20-30 players over the past 5 years.
  • Other players include Pathlab, Thonburi Clinical Labs, Bangkok Medical Labs, Medical Line Lab, Innotech Laboratories and others.

The Philippines Clinical Laboratory Market is expected to generate ~$1500 Mn by 2027F owing to Rising Health Consciousness, Government Regulations and Technological Advancements: Ken Research

Retrieved on: 
Tuesday, January 31, 2023

The market is led by N Health; having the major share of the Clinical Laboratory Market in Thailand.

Key Points: 
  • The market is led by N Health; having the major share of the Clinical Laboratory Market in Thailand.
  • Other players include Pathlab, Thonburi Clinical Labs, Bangkok Medical Labs, Medical Line Lab, Innotech Laboratories and others.
  • Around 60.0% of medical decisions regarding early disease diagnosis, patient prognosis and treatment selection are based on laboratory diagnostic results.
  • This will further lead to increase in market share in the overall Indonesia clinical laboratory market.

Diagnostic Imaging Services Market Size to Reach USD 67.94 Billion in 2030 | Emergen Research

Retrieved on: 
Monday, January 23, 2023

VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .
  • Rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry are some of the key factors boosting revenue growth of diagnostic imaging services market.
  • In addition, several product launches by key market players in diagnostic field are driving the growth of this market globally.
  • The diagnostic imaging services market is expected to register a CAGR of 5.8% over the forecast period and revenue is projected to increase from USD 40.80 in 2021 to USD 67.94 Billion in 2030.

Diagnostic Imaging Services Market Size to Reach USD 67.94 Billion in 2030 | Emergen Research

Retrieved on: 
Monday, January 23, 2023

VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .
  • Rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry are some of the key factors boosting revenue growth of diagnostic imaging services market.
  • In addition, several product launches by key market players in diagnostic field are driving the growth of this market globally.
  • The diagnostic imaging services market is expected to register a CAGR of 5.8% over the forecast period and revenue is projected to increase from USD 40.80 in 2021 to USD 67.94 Billion in 2030.

2022 HospeTrack Hospital Intelligence Insights for Bahrain - Featuring Fresenius Medical Care, Drager, Philips Healthcare and Siemens Healthineers Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022

Key medical device companies featured in the dataset include: Fresenius Medical Care, Drager, Philips Healthcare, Siemens Healthineers, GE Healthcare, Toshiba (Canon Medical Systems), Hitachi, Mindray.

Key Points: 
  • Key medical device companies featured in the dataset include: Fresenius Medical Care, Drager, Philips Healthcare, Siemens Healthineers, GE Healthcare, Toshiba (Canon Medical Systems), Hitachi, Mindray.
  • HospeTrack Hospital Intelligence for Bahrain, Guidance & Hospital Segmentation
    Provides brief methodology of research along with extensive detail around total coverage of hospitals in Bahrain, by type of hospital.
  • HospeTrack Hospital Intelligence for Bahrain, Insight Summary
    3.4 IB Penetration Summary for Bahrain by Care Level of Hospital, 2022
    4.
  • HospeTrack Hospital Intelligence for Bahrain, IB Base File
    Provides the raw data for all installed base equipment by account in Bahrain.

Indonesia IVD Market Exceeds $800 Million: Kalorama Information

Retrieved on: 
Wednesday, December 28, 2022

ARLINGTON, Va., Dec. 28, 2022 /PRNewswire-PRWeb/ -- In 2022, Indonesia's in vitro diagnostic (IVD) market is estimated to be about $812 million. The nation's leading IVD segments 2022 are point-of-care (POC) testing and microbiology and virology. The microbiology and virology segment includes immunoassays as well as molecular assays for infectious diseases including COVID-19 tests. Kalorama Information's finding was made in its latest report on in vitro diagnostic markets in select APAC nations, In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022.

Key Points: 
  • ARLINGTON, Va., Dec. 28, 2022 /PRNewswire-PRWeb/ -- In 2022, Indonesia's in vitro diagnostic (IVD) market is estimated to be about $812 million.
  • Kalorama Information's finding was made in its latest report on in vitro diagnostic markets in select APAC nations, In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 .
  • Indonesia is an archipelago spread across over 17,000 islands, which offers significant challenges to implement healthcare infrastructure across the country.
  • Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals.

Tele-Intensive Care Unit Global Market Report 2022: Increase in ICU Admission Rates & High Adoption of Tele-ICUs Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 3, 2022

The "Tele-Intensive Care Unit (ICU) Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tele-Intensive Care Unit (ICU) Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • In recent years, the number of patients requiring ICU care has increased without a corresponding growth in the availability of intensivists.
  • Critical care is in high demand due to a dearth of intensivists, a smaller number of ICUs, and the expansion of the pandemic.
  • Tele-ICU makes remote critical care and full-time bedside care accessible as the demand for critical care and full-time bedside care grows.